2009 Toyota Prius Base Hatchback 4-door 1.5l on 2040-cars

Auto blog

Toyota to end Australian production by 2017

There is more bad news for the Australian auto industry today, as Toyota has just announced that it will follow General Motors and Ford in shuttering its manufacturing operations on the continent. Production and assembly will cease by the end of 2017, but Toyota will remain in Australia as a sales and distribution company.
"We did everything that we could to transform our business, but the reality is that there are too many factors beyond our control that make it unviable to build cars in Australia," said Toyota Australia President and CEO Max Yasuda.
In an official statement, Yasuda said that the closure would directly affect 2,500 manufacturing employees and an unknown number of corporate workers. However, a report in the Australian newspaper The Age suggests that the jobs of 24,000 workers at Australian auto suppliers could also be in jeopardy. Toyota currently builds its Camry, Camry Hybrid, Aurion sedans in Australia, along with four-cylinder engines, and it plans to begin importing the Camry and Aurion after production stops.

Toyota prices fuel cell sedan $70K in Japan, coming to US and Europe next summer [w/video]

Toyota has finally unveiled its FCV hydrogen fuel cell sedan and its Japanese price. We won't have to wait too long to see the first of these revolutionary vehicles on the roads. It will go on sale in Japan in April 2015 and will come to the US and Europe later that summer.
In Japan, the FCV will be priced at roughly 7 million yen before taxes ($68,810 at current exchange rates). However, Toyota makes it clear in the press release that we shouldn't try to extrapolate US MSRP from that figure, saying that official pricing for the US and Europe has not yet been determined. As will be the case in the US, sales in Japan will be limited to parts of the country that already have a hydrogen refueling infrastructure (that means you, California).
The production version of the FCV looks almost identical to the concept from last year's Tokyo Motor Show. There is a new vertical strip of LEDs at each corner of the front air intake and real sideview windows, instead of the nubs on the prototype. The weird squiggles from the rear trim are also gone in favor of a more production-ready look, but the taillights survive the changes mostly intact.

Toyota wants improved crash scores with midcycle facelifts

The performances of some Toyotas in the Insurance Institute for Highway Safety's (IIHS) regimen of crash tests leave something to be desired. Consider the small overlap frontal crash test: only six Toyota, Lexus and Scion vehicles have undergone the new test, yet all but one of them received a poor rating. Osama Nagata, CEO of Toyota Motor Engineering & Manufacturing North America Inc., says midcycle vehicle updates are in the works to address the safety issues brought to light by the IIHS test, Automotive News reports. He confirmed that the RAV4 is getting safety updates following its crash test performance last month, but he didn't name any other models.
All three Toyotas that were tested - 2013 RAV4, 2012-2013 Prius V, 2012-2013 Camry - received poor ratings. The 2007-2012 Lexus ES 350 and 2006-2013 IS 250/350 also received poor ratings. The only other Toyota Motor Corp. vehicle to score better than poor is the 2014 Scion TC. It received an acceptable rating in the small overlap frontal crash test and is the only recent vehicle in Toyota's line-up to get the IIHS Top Safety Pick+ rating.
The small overlap front crash test measures the safety of a car when its front left corner is strikes an object during an accident, bypassing traditional crumple zones, which deform in a way to protect passengers. In 2009, automakers were alerted to the forthcoming addition of the test, which was first implemented last year, IIHS spokesman Russ Rader says. They responded with differing intensity, he says, pointing out that Subaru and Honda started incorporating design changes early on so their cars would perform well in the tests.